Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MoneyMouthon Jul 29, 2021 4:53pm
110 Views
Post# 33627370

RE:RE:wannabe

RE:RE:wannabe
I'm not sure why you think nothing has happened since January? They've made progress through multiple pharmaceutical collaborations dealing in stem cell derived islets. They've established a clinical investigator in Dr. Sam Wiseman for thyroid, who also completed preclinical tests this year and has been working on the regulatory package for a clinical trial. They announced additional positive results from the chicago trial. They've bolstered their global advisory board. They've made a strategic hire in recruiting Frank Shannon. They've been attending conferences. They put 30 million in the bank. Oh and the share price went up 500% this year. The fact that the markets did not react to all of these positive developments is not the fault of the company. They cannot force anyone to buy the stock.

Don't try and act like this year hasn't been successful, just compare all of the accomplishments from this year and last year and the year before. This year is just the appetizer before the main course coming. You guys act like amateurs when it comes to investing. If you bought into this thinking it wasn't a long hold then you made a rookie mistake and this must be the first biotech stock you've ever owned. I'm sorry but if you had misconceptions about what you were getting into then that is your bad and your mistake. Bottom line is patient investors will be rewarded so be patient and stfu.
<< Previous
Bullboard Posts
Next >>